Evaluation of a recombinant human adenovirus-5 vaccine administered via needle-free device and intramuscular injection for vaccination of pigs against swine influenza virus
- 1 November 2005
- journal article
- research article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 66 (11) , 1943-1947
- https://doi.org/10.2460/ajvr.2005.66.1943
Abstract
Objective—To evaluate the safety and efficacy of a human adenovirus-5 vaccine for protecting weaned pigs against swine influenza virus subtype H3N2 infection when administered via 2 injection methods. Animals—76 pigs. Procedure—6 groups of weaned pigs received a 10- fold serial dilution of recombinant adenovirus expressing H3 hemagglutinin and a constant amount of recombinant adenovirus expressing nucleoprotein, either via a needle-free injection device or by traditional IM injection. In each group of 10 pigs, 1 served as a nonvaccinated contact pig to monitor whether there was spread of vaccinial virus from pig to pig. Vaccinated pigs and nonvaccinated controls were challenged or sham-inoculated 5 weeks later. After challenge, pigs were observed for clinical signs and nasal secretions were tested for virus. On day 5 after challenge, pigs were euthanatized; lungs were examined for gross lesions, and bronchoalveolar lavage specimens were tested for virus replication. Results—A hemagglutination inhibition (HI) antibody response was elicited in a dose-dependent manner. Traditional IM administered vaccination induced consistently higher HI antibody responses than vaccination via needle-free injection, but the differences were not significant. Likewise, traditional IM administration was superior at reducing nasal virus shedding except at the highest dose, at which both methods blocked virus replication. The severity of lung lesions was reduced in a dose-dependent manner by both vaccination methods. Sentinel pigs did not seroconvert. Conclusions and Clinical Relevance—The human adenovirus-5 vaccine at high doses prevented nasal virus shedding after challenge exposure with both methods of administration. The replication-defective vaccine virus was not transmitted to sentinel pigs. (Am J Vet Res 2005;66:1943–1947)Keywords
This publication has 12 references indexed in Scilit:
- Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virusVaccine, 2004
- Recombinant adenovirus encoding the HA gene from swine H3N2 influenza virus partially protects mice from challenge with heterologous virus: A/HK/1/68 (H3N2)Archiv für die gesamte Virusforschung, 2002
- Phylogenetic analysis of H1N2 isolates of influenza A virus from pigs in the United StatesVirus Research, 2002
- Prevalence of swine influenza virus subtypes on swine farms in the United StatesArchiv für die gesamte Virusforschung, 2002
- The emergence of novel swine influenza viruses in North AmericaVirus Research, 2002
- Analysis of the quality of protection induced by a porcine influenza A vaccine to challenge with an H3N2 virusVeterinary Immunology and Immunopathology, 2001
- Evolution of Swine H3N2 Influenza Viruses in the United StatesJournal of Virology, 2000
- Systemic and mucosal immune responses to H1N1 influenza virus infection in pigsVeterinary Microbiology, 2000
- Infectious Causes of Abortion in SwineReproduction in Domestic Animals, 1999
- Diagnosis of porcine reproductive and respiratory syndrome using infected alveolar macrophages collected from live pigsVeterinary Microbiology, 1996